Immunotherapy with depigmented glutaraldehyde‐polymerized extracts: changes in quality of life

Abstract

Results of this study provided evidence that IT with depigmented, glutaraldehyde-modified allergen extracts was well-tolerated and added beneficial effects to AR treatment in pollen allergic patients eliciting an improvement in QOL enough to justify a change in the patient's treatment.